Glucagon is a hormone that signals the liver to release glucose into the bloodstream. It's typically given by injection to counteract severe hypoglycemia in people who have diabetes.

Altimmune’s pemvidutide failed to significantly improve fibrosis in MASH patients in a Phase IIb study. The biotech crashed ...

A dozen volunteers with severe type 1 diabetes showed clear improvements in their condition 12 months after receiving a ...

Testing their glucagon-packed micelles in lab experiments, the researchers found that they disassembled and released glucagon only in liquid environments that mimicked hypoglycemia in humans and ...

On readmission, in January, 1965, no new physical findings were evident, and it was not known whether the zinc glucagon was inactive or the worsening condition was due to progression of the disease.

There’s some new guidance on treating hypoglycemia, or low blood sugar, in long-term care communities. It’s specifically geared for healthcare workers, though anyone who is a caregiver for ...

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes, providing ...

This new obesity drug acts like three hormones: glucose-depending insulinotropic polypeptide (GIP), GLP-1, and glucagon. It helps you feel full after eating less and regulates blood sugar levels ...

On readmission, in January, 1965, no new physical findings were evident, and it was not known whether the zinc glucagon was inactive or the worsening condition was due to progression of the disease.